免疫疗法的进展和癌症治疗的创新治疗方法：特刊“意大利最新分子肿瘤学”的社论。
Advances in Immunotherapy and Innovative Therapeutic Approaches for Cancer Treatment: Editorial to the Special Issue "State-of-the-Art Molecular Oncology in Italy".
机构信息
Department of Systems Medicine, University of Rome "Tor Vergata", 00133 Rome, Italy.
出版信息
Int J Mol Sci. 2023 May 18;24(10):8929. doi: 10.3390/ijms24108929.
Abstract
Cancer remains one of the most common causes of death worldwide, mainly due to late diagnosis and the lack of efficient therapeutic options for patients with advanced diseases [...].
摘要
癌症仍然是全球最常见的死亡原因之一，主要是由于晚期诊断和缺乏针对晚期疾病患者的有效治疗选择[...]。
相似文献
1
Advances in Immunotherapy and Innovative Therapeutic Approaches for Cancer Treatment: Editorial to the Special Issue "State-of-the-Art Molecular Oncology in Italy".免疫疗法的进展和癌症治疗的创新治疗方法：特刊“意大利最新分子肿瘤学”的社论。
Int J Mol Sci. 2023 May 18;24(10):8929. doi: 10.3390/ijms24108929.
2
Thematic Issue: Immuno-Oncology and Immunotherapy.专刊主题：肿瘤免疫与免疫治疗。
Biochemistry (Mosc). 2019 Jul;84(7):693-694. doi: 10.1134/S0006297919070010.
3
Cancer Immunotherapy: A Simple Guide for Interventional Radiologists of New Therapeutic Approaches.癌症免疫疗法：介入放射科医师新治疗方法的简明指南。
Cardiovasc Intervent Radiol. 2019 Sep;42(9):1221-1229. doi: 10.1007/s00270-018-2074-1. Epub 2018 Sep 12.
4
Current advances in T-cell-based cancer immunotherapy.基于T细胞的癌症免疫疗法的当前进展。
Immunotherapy. 2014;6(12):1265-78. doi: 10.2217/imt.14.86.
5
Italian cancer figures, report 2012: Cancer in children and adolescents.《2012年意大利癌症数据报告：儿童和青少年癌症》
Epidemiol Prev. 2013 Jan-Feb;37(1 Suppl 1):1-225.
6
Emerging predictors of the response to the blockade of immune checkpoints in cancer therapy.癌症治疗中免疫检查点阻断反应的新兴预测因子。
Cell Mol Immunol. 2019 Jan;16(1):28-39. doi: 10.1038/s41423-018-0086-z. Epub 2018 Jul 12.
7
Recent advances and applications of CRISPR-Cas9 in cancer immunotherapy.CRISPR-Cas9 在癌症免疫治疗中的最新进展和应用。
Mol Cancer. 2023 Feb 16;22(1):35. doi: 10.1186/s12943-023-01738-6.
8
Top 10 Challenges in Cancer Immunotherapy.癌症免疫疗法的十大挑战。
Immunity. 2020 Jan 14;52(1):17-35. doi: 10.1016/j.immuni.2019.12.011.
9
Anticancer innovative therapy: Highlights from the ninth annual meeting.抗癌创新疗法：第九届年会亮点。
Cytokine Growth Factor Rev. 2020 Feb;51:1-9. doi: 10.1016/j.cytogfr.2019.12.002. Epub 2019 Dec 13.
10
Personalized Immuno-Oncology.个性化免疫肿瘤学。
Med Princ Pract. 2021;30(1):1-16. doi: 10.1159/000511107. Epub 2020 Aug 25.
引用本文的文献
1
Recent Advances in Artificial Intelligence to Improve Immunotherapy and the Use of Digital Twins to Identify Prognosis of Patients with Solid Tumors.人工智能在改善免疫疗法方面的最新进展，以及利用数字孪生技术来识别实体瘤患者预后的应用。
Int J Mol Sci. 2024 Oct 29;25(21):11588. doi: 10.3390/ijms252111588.
本文引用的文献
1
Anthelmintic Drugs as Emerging Immune Modulators in Cancer.抗蠕虫药物作为癌症治疗中的新兴免疫调节剂
Int J Mol Sci. 2023 Mar 29;24(7):6446. doi: 10.3390/ijms24076446.
2
Insights into the Peritumoural Brain Zone of Glioblastoma: and May Be Potential Drivers of Malignancy.脑胶质母细胞瘤瘤周脑区的研究进展：血管生成拟态和可能的恶性驱动因素。
Int J Mol Sci. 2023 Feb 2;24(3):2835. doi: 10.3390/ijms24032835.
3
Clinical Significance of Molecular Subtypes in Western Advanced Gastric Cancer: A Real-World Multicenter Experience.西方晚期胃癌分子亚型的临床意义：一项真实世界多中心经验。
Int J Mol Sci. 2023 Jan 3;24(1):813. doi: 10.3390/ijms24010813.
4
Programmed Cell Death-Ligand 1 in Head and Neck Squamous Cell Carcinoma: Molecular Insights, Preclinical and Clinical Data, and Therapies.程序性细胞死亡配体 1 在下咽鳞状细胞癌中的作用：分子见解、临床前和临床数据以及治疗方法。
Int J Mol Sci. 2022 Dec 6;23(23):15384. doi: 10.3390/ijms232315384.
5
Unraveling Mitochondrial Determinants of Tumor Response to Radiation Therapy.解析线粒体决定肿瘤对放射治疗反应的机制。
Int J Mol Sci. 2022 Sep 26;23(19):11343. doi: 10.3390/ijms231911343.
6
Nanotechnology Meets Oncology: A Perspective on the Role of the Personalized Nanoparticle-Protein Corona in the Development of Technologies for Pancreatic Cancer Detection.纳米技术与肿瘤学的结合：个体化纳米颗粒-蛋白冠在胰腺癌检测技术发展中的作用展望。
Int J Mol Sci. 2022 Sep 13;23(18):10591. doi: 10.3390/ijms231810591.
7
The Proteoglycan Glypican-1 as a Possible Candidate for Innovative Targeted Therapeutic Strategies for Pancreatic Ductal Adenocarcinoma.糖蛋白聚糖-1 作为胰腺导管腺癌创新靶向治疗策略的可能候选物。
Int J Mol Sci. 2022 Sep 7;23(18):10279. doi: 10.3390/ijms231810279.
8
Novel Nanotechnology Approaches to Overcome Drug Resistance in the Treatment of Hepatocellular Carcinoma: Glypican 3 as a Useful Target for Innovative Therapies.新型纳米技术方法克服肝癌治疗中的药物耐药性：Glypican 3 作为创新疗法的有用靶点。
Int J Mol Sci. 2022 Sep 2;23(17):10038. doi: 10.3390/ijms231710038.
9
Evaluation of the Molecular Landscape in PD-L1 Positive Metastatic NSCLC: Data from Campania, Italy.评估 PD-L1 阳性转移性非小细胞肺癌的分子谱：来自意大利坎帕尼亚的数据。
Int J Mol Sci. 2022 Aug 1;23(15):8541. doi: 10.3390/ijms23158541.
10
Monitoring Somatic Genetic Alterations in Circulating Cell-Free DNA/RNA of Patients with "Oncogene-Addicted" Advanced Lung Adenocarcinoma: A Real-World Clinical Study.监测“致癌基因成瘾”晚期肺腺癌患者循环游离 DNA/RNA 中的体细胞遗传改变：一项真实世界的临床研究。
Int J Mol Sci. 2022 Aug 1;23(15):8546. doi: 10.3390/ijms23158546.
Zotero 插件